Vallon Pharmaceuticals (VLON) Competitors

Tenax Therapeutics (NASDAQ:TENX) and Vallon Pharmaceuticals (NASDAQ:VLON) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, community ranking, media sentiment, dividends and profitability.

Does the MarketBeat Community believe in TENX or VLON?

Tenax Therapeutics received 139 more outperform votes than Vallon Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Vallon Pharmaceuticals an outperform vote while only 58.58% of users gave Tenax Therapeutics an outperform vote.

Company	Underperform	Outperform
Tenax Therapeutics	Outperform Votes 140 58.58%	Underperform Votes 99 41.42%
Vallon Pharmaceuticals	Outperform Votes 1 100.00%	Underperform Votes No Votes

Do institutionals & insiders have more ownership in TENX or VLON?

1.7% of Tenax Therapeutics shares are owned by institutional investors. Comparatively, 8.7% of Vallon Pharmaceuticals shares are owned by institutional investors. 1.9% of Tenax Therapeutics shares are owned by company insiders. Comparatively, 37.3% of Vallon Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has more risk & volatility, TENX or VLON?

Tenax Therapeutics has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. Comparatively, Vallon Pharmaceuticals has a beta of -1.14, indicating that its stock price is 214% less volatile than the S&P 500.

Is TENX or VLON more profitable?

Vallon Pharmaceuticals' return on equity of -65.79% beat Tenax Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenax Therapeutics	N/A	-65.79%	-58.31%
Vallon Pharmaceuticals	N/A	-230.48%	-124.89%

Which has stronger valuation and earnings, TENX or VLON?

Vallon Pharmaceuticals has higher revenue and earnings than Tenax Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenax Therapeutics	N/A	N/A	-$7.71M	N/A	N/A
Vallon Pharmaceuticals	$100K	69.76	-$7.02M	-$0.78	-0.66

Does the media favor TENX or VLON?

In the previous week, Tenax Therapeutics had 1 more articles in the media than Vallon Pharmaceuticals. MarketBeat recorded 1 mentions for Tenax Therapeutics and 0 mentions for Vallon Pharmaceuticals. Vallon Pharmaceuticals' average media sentiment score of 0.98 beat Tenax Therapeutics' score of 0.00 indicating that Tenax Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Tenax Therapeutics	Positive
Vallon Pharmaceuticals	Neutral

Do analysts prefer TENX or VLON?

Tenax Therapeutics presently has a consensus price target of $480.00, indicating a potential upside of 12,943.48%. Given Vallon Pharmaceuticals' higher probable upside, equities research analysts clearly believe Tenax Therapeutics is more favorable than Vallon Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenax Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Vallon Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Tenax Therapeutics beats Vallon Pharmaceuticals on 8 of the 13 factors compared between the two stocks.